Financial Daily from THE HINDU group of publications
Saturday, Feb 25, 2006


Group Sites

Corporate - Regulatory Bodies & Rulings

USFDA nod for Aurobindo's Lisinopril

Our Bureau

Hyderabad, Feb. 24

Aurobindo Pharma Ltd has announced that the US Food Drug Administration (USFDA) has approved its Lisinopril tablets 2.5, 5, 10, 20, 30 and 40 mg.

In a press release here on Friday, Aurobindo said Lisinopril is an angiotensin converting enzyme inhibitor used for controlling blood pressure, treating heart failure and preventing kidney damage in people with hypertension or diabetes. They also benefit patients, who have had heart attacks.

According to the company, the market opportunity for the current approval is around $600 million. The product is manufactured at FDA approved multi purpose plant situated at Bachupally (Unit-III) in the city outskirts.

The company said this cardio vascular system segment, generally referred as `prils', has a turnover of over $3.5 billion in the US market alone and is a key component of the company product portfolio. The Hyderabad-based Aurobindo Pharma has a comprehensive portfolio of over 10 prils in its pipeline and is vertically integrated, the release said.

More Stories on : Regulatory Bodies & Rulings | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
JSW Steel hikes price

Glenmark trials on diabetes drug
Dutch firm refutes vaccine charges
Ministry yet to settle GAIL, ONGC row
Birlas want probe by Telecom Dept
Madhucon Projects allots GDRs
Electrosteel Castings FCCB issue likely in April
ONGC told not to award deal
Kerala: Audit by CAs in co-op banks, societies urged
Amtek Auto to bring 2 group cos under fold
Videocon to bid for Daewoo Elect
Rain Calcining floats SPV for routing overseas investments
Stone for footwear plant to be laid today
Gateway Distriparks to invest Rs 200 cr for new facilities
US co opens innovation Chennai centre
PSL commissions Vizag plant
Areva T&D to invest euro 50 m in power sector
POSCO India MD appointed to board
USFDA nod for Aurobindo's Lisinopril
AIMA interactive meet
ITC unit to apply for carbon credits
Water, oil to drive Krohne Marshall growth
Jessop on expansion drive
Hetero unveils bird flu drug
New Mercedes models unveiled
DaimlerChrysler to roll out Actros trucks, luxury buses

The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line